Antitumor responses triggered by this irradiated pDC line were confirmed in tumor-bearing humanized mice that received a subcutaneous injection of irradiated pDCs loaded with melanoma-derived antigens where CD8+ T-cells were present in the tumor site and the draining lymph nodes [80]. This evidence concerns the gene CD8A and neoplasm.